Triple Therapy in T1DM

Clinical trial NCT03899402 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03899402
Sponsor: State University of New York at Buffalo
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus

Start date: 2019-05-01
Primary completion: 2026-01-31
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.